-
2 weeks ago | 
hyperallergic.com | Natalie Haddad |Lisa Zhang |John Yau |Seph Rodney |Alexandra Thomas
We rely on readers like you to fund our journalism. If you value our coverage and want to support more of it, please join us as a member. Sometimes there’s nothing more satisfying than encountering the work of a creative force. Our favorite shows this week are each centered on a single figure. Some are visual artists, ranging from historical innovators (Volodymyr Tatlin) to under-appreciated names (Judy Linn) to perhaps unknown names (Abraham Lincoln Walker).
-
2 weeks ago | 
hyperallergic.com | Valentina Di Liscia |Lisa Zhang |Alexandra Thomas |Sophia Stewart |Albert Mobilio |Lauren Ford
We rely on readers like you to fund our journalism. If you value our coverage and want to support more of it, please join us as a member. It feels both eerie and stabilizing to read Octavia E. Butler’s books in the year 2025, when the realities she prophesized have come true. But the exhibition catalog American Artist: Shaper of God grants us a welcome opportunity to reflect on the lessons we can glean from her legacy, which critic Alexandra M.
-
3 weeks ago | 
hyperallergic.com | Natalie Haddad |Lisa Zhang |Debra Brehmer |Alexis Clements |Alexandra Thomas
We rely on readers like you to fund our journalism. If you value our coverage and want to support more of it, please join us as a member. The exhibitions below ask viewers to engage their senses and spend time with art that’s slower to reveal itself. That may means noticing details you’d otherwise miss, in the work of Madalena Santos Reinbolt and Deborah-Joyce Holman.
-
1 month ago | 
hyperallergic.com | Natalie Haddad |Hrag Vartanian |Lisa Zhang |Alexandra Thomas |Jasmine Weber
We rely on readers like you to fund our journalism. If you value our coverage and want to support more of it, please join us as a member. This is a week of big statements by artists and expanded possibilities by curators and gallerists, past and present. If you haven’t already made the trip to Pioneer Works in Brooklyn’s Red Hook neighborhood to see American Artist’s exploration of author Octavia E. Butler, we highly recommend it.
-
Nov 4, 2024 | 
hyperallergic.com | Alexandra Thomas
We rely on readers like you to fund our journalism. If you value our coverage and want to support more of it, consider supporting us as a member. Join Us Elizabeth Catlett: A Black Revolutionary and All That It Impliesassumes the prodigious task of showcasing nearly 50 years of the prolific artist’s dynamic artwork and abundant political offerings.
-
Oct 9, 2024 | 
brnw.ch | Alexandra Thomas |Erica L. Mayer |Angela DeMichele
COMMENTS AND CONTROVERSIES The use of tissue-based genomic assays as a tool for risk stratification in early-stage estrogen receptor (ER)–positive breast cancer marks a significant advance over the previous paradigm which relied largely on extent of disease to assess risk.1-3 This advance has transformed care, with genomic assays identifying patients who do not benefit from adjuvant chemotherapy.4 However, prospective trials testing the clinical utility of genomic assays largely excluded...
-
Oct 1, 2024 | 
hyperallergic.com | Alexandra Thomas
We rely on readers like you to fund our journalism. If you value our coverage and want to support more of it, consider supporting us as a member. Join Us What is implied in the bold designation “Black revolutionary artist”? For Elizabeth Catlett, it encapsulates the way her life, legacy, and artwork together offer a blueprint for leftist Black feminist engagement with the arts.
-
Sep 14, 2024 | 
nature.com | Katia Khoury |Hope Rugo |Rita Nanda |Alexandra Zimmer |Judy Boughey |Christos Vaklavas | +11 more
AbstractAmong the goals of patient-centric care are the advancement of effective personalized treatment, while minimizing toxicity. The phase 2 I-SPY2.2 trial uses a neoadjuvant sequential therapy approach in breast cancer to further these goals, testing promising new agents while optimizing individual outcomes. Here we tested datopotamab–deruxtecan (Dato-DXd) in the I-SPY2.2 trial for patients with high-risk stage 2/3 breast cancer.
-
Sep 13, 2024 | 
nature.com | Rita Nanda |Hope Rugo |Judy Boughey |Kevin Kalinsky |Christos Vaklavas |Claudine Isaacs | +8 more
AbstractSequential adaptive trial designs can help accomplish the goals of personalized medicine, optimizing outcomes and avoiding unnecessary toxicity.
-
Jul 30, 2024 | 
hyperallergic.com | Alexandra Thomas
HARTFORD, Connecticut — Styling Identities: Hair’s Tangled Histories at the Wadsworth Atheneum combines global contemporary art with a deep commitment to Hartford-based storytelling. The exhibition surveys local and global hair culture through various cultural and political lenses. Spread across several galleries, it includes a vast range of historic and contemporary art, interactive installations, material culture, and thought-provoking didactics.
